Immunotherapy for Infectious Diseases

Tuberculosis and Other Mycobacterial Infections 295
18. Wallis RS, Paranjape R, Phillips M. Identification by two-dimensional gel electrophoresis
of a 58-kilodalton tumor necrosis factor-inducing protein of M. tuberculosis. Infect
Immun 1993; 61:627–632.
19. Moreno C, Taverne J, Mehlert A, Bate CA, Brealey RJ, Meager A, Rook GA, Playfair JH.
Lipoarabinomannan from M. tuberculosis induces the production of tumour necrosis factor
from human and murine macrophages. Clin Exp Immunol 1989; 76:240–245.
20. Wallis RS, Fujiwara H, Ellner JJ. Direct stimulation of monocyte release of interleukin 1
by mycobacterial protein antigens. J Immunol 1986; 136:193–196.
21. Valone SE, Rich EA, Wallis RS, Ellner JJ. Expression of tumor necrosis factor in vitro by
human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and
mycobacterial antigens. Infect Immun 1988; 56:3313–3315.
22. Bermudez LE. Production of transforming growth factor-beta by M. avium-infected human
macrophages is associated with unresponsiveness to IFN-gamma. J Immunol 1993;
150:1838–1845.
23. Kasahara K, Kobayashi K, Shikama Y, et al. The role of monokines in granuloma formation
in mice: the ability of interleukin 1 and tumor necrosis factor-alpha to induce lung
granulomas. Clin Immunol Immunopathol 1989; 51:419–425.
24. Denis M, Gregg EO, Ghandirian E. Cytokine modulation of M. tuberculosis growth in
human macrophages. Int J Immunopharmacol 1990; 12:721–727.
25. Bermudez LE, Young LS. Tumor necrosis factor, alone or in combination with IL-2, but
not IFN-gamma, is associated with macrophage killing of M. avium complex. J Immunol
1988; 140:3006–3013.
26. Rose RM, Fuglestad JM, Remington L. Growth inhibition of M. avium complex in human
alveolar macrophages by the combination of recombinant macrophage colony-stimulating
factor and interferon-gamma. Am J Respir Cell Mol Biol 1991; 4:248–254.
27. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor
stimulate human macrophages to restrict growth of virulent M. avium and to kill avirulent
M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.
J Leukoc Biol 1991; 49:380–387.
28. Bermudez LE, Young LS. Recombinant granulocyte-macrophage colony-stimulating factor
activates human macrophages to inhibit growth or kill M. avium complex. J Leukoc
Biol 1990; 48:67–73.
29. Denis M, Gregg EO. Recombinant tumour necrosis factor-alpha decreases whereas recombinant
interleukin-6 increases growth of a virulent strain of M. avium in human
macrophages. Immunology 1990; 71:139–141.
30. Kaneko H, Yamada H, Mizuno S, et al. Role of tumor necrosis factor-alpha in
Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient
mice. Lab Invest 1999; 79:379–386.
31. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis
factor in the development of bactericidal granulomas during BCG infection. Cell 1989;
56:731–740.
32. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufmann SH. Lethal tuberculosis
in interleukin-6-deficient mutant mice. Infect Immun 1997; 65:4843–4849.
33. Bellamy R, Ruwende C, Corrah T, et al. Tuberculosis and chronic hepatitis B virus infection
in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179:721–724.
34. Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CG, Hill AV. Association of vitamin
D receptor genotype with leprosy type. J Infect Dis 1999; 179:187–191.
35. Denis M. Killing of M. tuberculosis within human monocytes: activation by cytokines and
calcitriol. Clin Exp Immunol 1991; 84:200–206.
36. Rook GA, Taverne J, Leveton C, Steele J. The role of gamma-interferon, vitamin D3
metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology
1987; 62:229–234.